Catalent has initiated layoffs affecting between 200 to 350 employees in Maryland due to a significant shift in demand from a major customer. The company emphasized its commitment to supporting departing employees during this transition. These cuts come in the context of a challenging job market for the life sciences sector in Maryland, which has already seen thousands of layoffs this year. Additionally, Catalent is involved in ongoing legal issues regarding the alleged removal of confidential files by a former employee. The situation reflects the volatility of the gene therapy industry and the pressures faced by contract development and manufacturing organizations (CDMOs).
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://biobuzz.io/news/breaking-catalent-rumored-350-layoffs-in-maryland-as-biotech-sector-continues-to-shed-jobs/
